MedTrace Logo

Outcomes of Treatment for Trapeziometacarpal Osteoarthritis

NCT01724853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177

Last updated 2013-12-02

No results posted yet for this study

Summary

The main objective of the study is the evaluation of the outcomes following treatment for TMC OA using a set of variables covering all OMERACT categories as well as the dimensions of the International Classification of Functioning, Disability and Health (ICF). Secondary aims are the analysis of the determinants of patient satisfaction with the treatment result, the evaluation of the psychometric properties of the Michigan Hand Outcomes Questionnaire (MHQ), which has not yet been established in TMC OA patients, as well as the economic impact associated with TMC OA.

Conditions

  • Osteoarthrosis of the Carpometacarpal Joint of the Thumb

Interventions

PROCEDURE

Surgery

Resection suspension interposition arthroplasty or Arthrodesis

OTHER

Conservative

Injection

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Schulthess Klinik

    lead OTHER

Principal Investigators

  • Daniel Herren, Dr. · Department of Handsurgery

  • Miriam Marks, MSc. · Department of Research and Development

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724853 on ClinicalTrials.gov